Clinical Trials Directory

Trials / Unknown

UnknownNCT05646628

The Impact of Comorbid Chronic Pain on Older Adults With Depression in Behavioral Activation

The Impact of Comorbid Chronic Pain on Older Adults With Depression in Behavioral Activation: A Nested Qualitative Sub-Study of Participants in the BASIL+ Trial

Status
Unknown
Phase
Study type
Observational
Enrollment
10 (estimated)
Sponsor
Teesside University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

This qualitative nested sub-study will aim to explore how chronic pain (as defined as pain lasting for more than 3 months) impacts older adults' depression and treatment in a brief psychological therapy of behavioral activation (BA)

Detailed description

The BASIL + trial (Behavioral Activation in Social Isolation) is a National Institute of Health Research (NIHR) funded and approved trial sponsored by Tees, Esk and Wear Valleys NHS Foundation Trust (TEWV) and led by the University of York in the United Kingdom (UK). Behavioral Activation (BA) is a type of support that may be beneficial for individuals who suffer from social isolation and/ or depression symptoms. BA assists in the continuation or introduction of activities that are significant to patients. These exercises may be beneficial to both physical and emotional health. The BASIL+ study aims to find out if BA helps reduce or prevent depression and loneliness in older adults who have ongoing health conditions during isolation in the pandemic due to COVID-19. Chronic pain affects approximately 50-60% of UK older adults and often coexists with depression. This comorbid indication affects approximately 13% of older adults. The literature on the impact of pain on depression outcomes has been steadily rising. Patients who suffer from depression with comorbid pain report significantly lower benefits, including less relief from depressive symptoms and limits the effectiveness of collaborative care for older adults with depression in the US. The collaborative care focused on antidepressant therapy and problem-solving therapy. Together, these findings suggest that pain may be a potential barrier to depression treatment response. It is unknown, however, how chronic pain impacts depression and the treatment of BA. This sub-study nested in the BASIL+ trial provides an opportunity to explore how chronic pain impacts depression and the treatment they received

Conditions

Interventions

TypeNameDescription
BEHAVIORALQualitative InterviewsSemi-structured Qualitative Interviews

Timeline

Start date
2022-11-28
Primary completion
2023-07-01
Completion
2024-03-01
First posted
2022-12-12
Last updated
2023-04-20

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05646628. Inclusion in this directory is not an endorsement.